SCHEMBL19989530

SCHEMBL19989530

CCc1nc2ccccc2c(-n2cnc3c(C(=O)OC)cc(N4CCOCC4)cc32)c1C

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3R2 O00459 9/20 0.65
PIK3C2B O00750 3/20 0.43
MAPT P10636 6/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
GAA P10253 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
LMNA P02545 2/20 0.41
HTT P42858 2/20 0.41
HPGD P15428 1/20 0.41
NTSR1 P30989 1/20 0.41
NOD2 Q9HC29 1/20 0.41
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19988898 0.92 PIK3R2 (0.69) PIK3R2PIK3C2BMAPTMEN1KMT2A
SCHEMBL19989228 0.90 PIK3R2 (0.67) PIK3R2PIK3C2BMAPTSMN1; SMN2GAA
SCHEMBL19989425 0.89 PIK3R2 (0.65) PIK3R2PIK3C2BMAPTMEN1KMT2A
SCHEMBL19989350 0.86 PIK3R2 (0.65) PIK3R2PIK3C2B
SCHEMBL19989071 0.80 PIK3R2 (0.69) PIK3R2PIK3C2BMAPTMEN1KMT2A
SCHEMBL19988964 0.79 PIK3R2 (0.67) PIK3R2PIK3C2BMAPTSMN1; SMN2GAA
SCHEMBL20009344 0.79 PIK3C2B (0.49) PIK3R2PIK3C2B
SCHEMBL20000204 0.79 PIK3R2 (0.78) PIK3R2
SCHEMBL19989330 0.78 PIK3R2 (0.68) PIK3R2PIK3C2BPKM
SCHEMBL19989135 0.77 PIK3R2 (0.64) PIK3R2PIK3C2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180086747-A1 PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS GILEAD SCIENCES, INC. 2018-03-29 US disclosed
WO-2018057808-A1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS GILEAD SCIENCES, INC. (US) 2018-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086747-A1 PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS PIK3CA, AKT3, TNNI3K PIK3R2 18/4885PIK3C2B 20/4885MAPT 146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.